Advanced Search

Study Preview



Study Title and Description

Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus.



Key Questions Addressed
6 Key Question 6. What is the effectiveness of currently recommended antiviral treatments in improving health outcomes in patients with HCV infection?
  • Comments Comments (
    0
    ) |
7 Key Question 7. What is the effectiveness of currently recommended antiviral treatments in achieving a SVR in patients with HCV infection?
  • Comments Comments (
    0
    ) |
8 Key Question 8. What are the harms of currently recommended antiviral treatments?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus.
Author Chuang WL., Chien RN., Peng CY., Chang TT., Lo GH., Sheen IS., Wang HY., Chen JJ., Yang JC., Knox SJ., Gao B., Garrison KL., Mo H., Pang PS., Hsu YC., Hu TH., Chu CJ., Kao JH.
Country Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Year 2016
Numbers Pubmed ID: 26841930

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.